Sharp T
Department of Pharmacology, Mansfield Road, OxfordOX1 3QT, U.K.
ArticlePsilocybin
Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.
ArticlePsychedelics
Emerging therapeutic opportunities for psychedelic and related drugs.
PreprintPsychedelics
Editorial Emerging therapeutic opportunities for psychedelic and related drugs
ArticleDMT
Vigilance state dissociation induced by 5-MeO-DMT in mice.
ArticlePsilocybin
Evidence that 5-HT<sub>2A</sub> receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.
ArticlePsilocybin
Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT<sub>2A</sub> receptor agonists.
PreprintDMT
Vigilance state dissociation induced by 5-MeO DMT in mice
PreprintPsilocybin
Increased 5-HT <sub>2A</sub> receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics
PreprintDMT
Sleep-like state during wakefulness induced by psychedelic 5-MeO-DMT in mice
ArticlePsilocybin
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.
PreprintPsilocybin
Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice
ArticlePsilocybin